Top 10 Thoracic Catheter Companies Advancing Drainage Management and Post-Surgical Patient Care Solutions

The wave of mounting advancements in the healthcare industry over the recent years has also touched thoracic catheters, driving medical instrument companies into developing and innovating advanced systems for drainage management. In a move showcasing its recent innovations, Able Medical Devices, in January 2026, shared plans for unveiling its latest sternal closure solutions at the Louisiana-based Society of Thoracic Surgeons (STS) 2026 Annual Meeting. The step depicts the company’s commitment to enhancing surgical efficiency and patient outcomes. In addition to product developments, several studies are being conducted for assessing the efficacy of newly developed thoracic catheter systems in various surgical procedures. An example is a May 2025 study published in the JACC: Cardiovascular Interventions, which unveiled a novel self-centering catheter designed for helping during TAVR (Transcatheter Aortic Valve Replacement) for the retrograde crossing of a severely stenotic aortic valve. The solution was first deployed by the Mayo Clinic and has been found to be effective and safe. This study was conducted in adult patients with severe symptomatic aortic stenosis (AS) who were undergoing transfemoral TAVR.

The rise in such developments and the increase in post-operative care amid the soaring volume of surgical procedures is likely to push the demand for high-quality catheters. According to Fortune Business Insights, the global market for thoracic catheters is poised to touch USD 399.0 million by 2034 from a value of USD 311.8 million in 2026, depicting a CAGR of 3.7% over 2026 to 2034. Used for draining blood, air, pus, or other fluids from the pleural space, these catheters are made from biocompatible materials and are available in a range of sizes for meeting diverse requirements.

What Strategies are Thoracic Catheter Players Adopting?

To gain footing, eminent companies are investing in the development of new products and collaborating with other players. These companies are also centered on efforts for enhancing procedural outcomes and tapping into the surging demand for improved healthcare infrastructure. Additional steps that these players are deploying comprise supply contracts and portfolio enhancement.

The top 10 thoracic catheter companies and the pivotal strategies that they are deploying to build a strong industry standing have been discussed here:

1. Teleflex Incorporated

With its base in the U.S., Teleflex Incorporated offers drainage solutions, including thoracic catheters and accessories. The company’s Pleur-evac™ range features smooth and optimal drainage and has been designed for easy insertion while lowering the risk of trauma. In January 2025, Vizient awarded Teleflex Incorporated a contract for the supply of the latter’s arterial catheters and central venous access catheters.

2. Getinge AB

Getinge AB develops a range of firm and soft PVC catheters. The Sweden-headquartered company sells its products across over 135 nations and is aimed at optimizing workflows and enhancing clinical outcomes across the globe. Some of the key offerings on its portfolio comprise the Atrium Express Mini 500 Mobile Dry Seal Drain and the Atrium Oasis Dry Suction Water Chest Seal Drain.

3. BD

Medtech player BD conducts its business through four segments that include Connected Care, Medical Essentials, Interventional, and Biopharma Systems. With headquarters located in the U.S., this thoracic catheter company develops catheter systems for effective drainage management along with other technologies. In June 2021, the company secured the 510(k) clearance for the PeritX™ Peritoneal Catheter System from the U.S. FDA for the drainage of recurrent, symptomatic non-malignant ascites.

4. Cardinal Health

S.-based Cardinal Health has trocar, silicone, PVC, and soft PVC catheters on its portfolio. The company’s Argyle™ range comprises clear thermosensitive PVC-based catheters that are disposable, single use, and sterile in nature. Furthermore, the company also offers a chest drainage lineup for aiding clinicians in rendering effective cardiac care.

5. Cook Medical

Cook Medical’s thoracic catheters portfolio covers tubes and catheters for pericardial and pleural drainage. The U.S.-headquartered company offers products in a range of sizes and designs for meeting the specific requirements of various procedures. The company’s Wayne Pneumothorax Catheter Set and Tray – Seldinger has been equipped with the Cook Chest Drain Valve for facilitating the removal of air from pleural cavity.

6. Braun

B. Braun develops an array of catheters suitable for meeting the drainage requirements of patients in various procedures. The company, with its base in Germany, has an extensive portfolio of 5,000 products across various medical disciplines. In June 2024, B. Braun Interventional Systems Inc., rolled out its new ACCEL® All-Purpose and Biliary Drainage Catheters with TrueGlide® Hydrophilic Coating for percutaneous drainage.

7. Medela

With headquarters situated in Switzerland, Medela offers various surgical care solutions including products designed for chest drainage. The company’s Thopaz+ has been claimed to be a highly effective solution for post-cardiac surgery care and immediate chest drain management. In February 2026, Vizient awarded Medela a contract for its Thopaz+ Digital Chest Drainage System. This reflects the expanding role of digital technologies in enhancing patient outcomes and clinical decision-making following cardiothoracic procedures.

8. Vygon

Vygon, one of the top 10 thoracic catheter companies, provides numerous solutions for pleural and thoracic drainage. Some of the significant offerings of the France-based medical instrument developer comprise the non-return valve for thoracic drainage (Heimlich type) and thoracic trocar drain code 636. In February 2026, the company acquired Stiletto for strengthening its vascular access leadership for improving patient outcomes and simplifying insertion.

9. Poly Medicure Ltd.

Founded in 1997, Poly Medicure is focused on deploying state-of-the-art technologies for providing superior healthcare solutions to its clientele. The India-based thoracic catheter company has a range of solutions on its portfolio, including Ultra Cath Novo-Trocar 90173-90181 and Ultra Cath Novo-Straight 90080-90185. The company showcased its incline toward takeovers in September 2025 when it inked a definitive agreement for acquiring a 90% stake in PendraCare Group, a Netherlands-based company specialized in the development and sale of cardiology catheter solutions.

10. Redax S.p.A.

Italy-based Redax conducts advanced solutions by investing in research and development. The company is centered on providing high quality products that span thoracic catheters, fluted drains, and portable chest drains. The company’s Redax Silicone catheters help improve patient comfort and outcomes and reduce pain in early ambulation.

Climbing Pleural Effusion Management Demand to Set the Stage for Effective Catheter Development

Over the coming years, the elevated need for rendering effective post-operative care amid the surging volume of medical procedures is likely to foster the adoption of high-quality thoracic catheters. The demand for long-term drainage options is poised to depict a climb as the demand for pleural effusion management records a rise across the medical industry. Some of the effective interventions comprise indwelling pleural catheters and chest drain insertion. The deployment of targeted therapies for effectively addressing pleural effusions and the performance of pleural biopsies for receptor status profiling and gene expression are pushing the demand for specialized catheters.